CALB (03931) announced that on December 23, 2025, the company successfully bid for the target equity offered for sale in a public tender held at the Beijing Equity Exchange. Subsequently, on December 24, 2025, CALB entered into an equity transfer agreement with the seller, agreeing to acquire the target equity for RMB 660 million. The company has received the "State-Owned Asset Transaction Certificate" issued by the Beijing Equity Exchange for this acquisition as of December 24, 2025.
Prior to this transaction, CALB and the seller held 51% and 49% stakes in the target company, respectively. Upon completion of the acquisition, CALB's ownership in the subsidiary will increase from 51% to 59.3155%, while the target company will remain a non-wholly owned subsidiary.
The Wuhan subsidiary has demonstrated efficient production line construction and stable revenue growth since its establishment, with sound profitability and manageable debt-to-asset ratios. Based on positive growth expectations for the Wuhan subsidiary, CALB participated in the public tender. This acquisition will further strengthen the company's stake in its Wuhan operations.
Comments